Publications by authors named "Colin Crean"

Claim this Profile
G
Growth factor independence 1 expression in myeloma cells enhances their growth, survival, and osteoclastogenesis.
Daniela N Petrusca, Denise Toscani, Feng-Ming Wang, Cheolkyu Park, Colin D Crean

J Hematol Oncol· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cell Adhesion Molecule CD166 Drives Malignant Progression and Osteolytic Disease in Multiple Myeloma.
Linlin Xu, Khalid S Mohammad, Hao Wu, Colin Crean, Bradley Poteat

Cancer Res· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted nuclear factor-kappaB suppression enhances gemcitabine response in human pancreatic tumor cell line murine xenografts.
Joshua A Waters, Jesus Matos, Michele Yip-Schneider, Juan R Aguilar-Saavedra, Colin D Crean

Surgery· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FGF23 is elevated in multiple myeloma and increases heparanase expression by tumor cells.
Attaya Suvannasankha, Douglas R Tompkins, Daniel F Edwards, Katarina V Petyaykina, Colin D Crean

Oncotarget· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Temozolomide-mediated DNA methylation in human myeloid precursor cells: differential involvement of intrinsic and extrinsic apoptotic pathways.
Haiyan Wang, Shanbao Cai, Aaron Ernstberger, Barbara J Bailey, Michael Z Wang, Colin Crean

Clin Cancer Res· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The novel histone deacetylase inhibitor, AR-42, inhibits gp130/Stat3 pathway and induces apoptosis and cell cycle arrest in multiple myeloma cells.
Shuhong Zhang, Attaya Suvannasankha, Colin D Crean, Valerie L White, Ching-Shih Chen

Int J Cancer· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical activity of a novel multiple tyrosine kinase and aurora kinase inhibitor, ENMD-2076, against multiple myeloma.
Xiaojing Wang, Anthony L Sinn, Karen Pollok, George Sandusky, Shuhong Zhang, Colin D Crean

Br J Haematol· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antimyeloma effects of a sesquiterpene lactone parthenolide.
Attaya Suvannasankha, Colin D Crean, Rajasubramaniam Shanmugam, Sherif S Farag, Rafat Abonour

Clin Cancer Res· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MOZ and MOZ-CBP cooperate with NF-kappaB to activate transcription from NF-kappaB-dependent promoters.
Edward M Chan, Rebecca J Chan, Elisha M Comer, Robert J Goulet, Colin D Crean

Exp Hematol· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
OSU-03012, a novel celecoxib derivative, is cytotoxic to myeloma cells and acts through multiple mechanisms.
Shuhong Zhang, Attaya Suvannasankha, Colin D Crean, Valerie L White, Amy Johnson

Clin Cancer Res· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Temporal gene expression profile of human precursor B leukemia cells induced by adhesion receptor: identification of pathways regulating B-cell survival.
Anne Laurence Astier, Ronghui Xu, Marek Svoboda, Esther Hinds, Olivier Munoz, Colin Daniel Crean

Blood· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis